Skip to main content

Fidelity — Portfolio, Page 6

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

258
Companies
$29.2B
Total invested
$175.8M
Avg. check
54
Industries
Biotechnology 9Health Care 6Therapeutics 5Biopharma 4Medical 4Pharmaceutical 4+48 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 121–144 of 258
Metsera
November 2024

Metsera is a clinical‐stage biotech firm developing oral & injectable hormone therapies to treat obesity & related metabolic diseases.

Biopharma · New York$215.0M Series B
Saluda Medical
November 2025

Saluda Medical is a commercial-stage medical device company that develops treatments for chronic neurological conditions.

Health Care · Bloomington$30.0M Venture - Series Unknown
Carbon
November 2025

Carbon is a company that provides high-tech, waste reducing 3D printing services.

3D Printing · Redwood City$60.0M Venture - Series Unknown
Ankyra
November 2021

Ankyra is a biotech company developing anchored immunotherapy for cancer treatments.

Biotechnology · Boston$45.0M Series B
Starry
October 2021

Starry is an internet company that creates easy-to-use Wi-Fi products and radical ways to get Internet service.

Hardware · Boston$150.0M Post-IPO Debt
Axcella
October 2022

Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.

Biotechnology · Cambridge$34.2M Post-IPO Equity
Corastone
March 2026

Corastone is a technology company that provides infrastructure for private-market investing.

Angel Investment · HoustonSeries Unknown
Theia Insights
February 2026

Leveraging AI to transform information into insights

Analytics · Cambridge$8.0M Series Unknown
Beta Technologies
February 2026

Beta Technologies builds electric VTOL and CTOL aircraft, charging systems, and training programs focused on operational simplicity.

Aerospace · South BurlingtonPost Ipo Secondary
Glide Identity
February 2026

Glide Identity provides SIM-based cryptographic authentication and verification systems using telecom network APIs.

Cyber Security · San Francisco$5.0M Grant
Skyryse
February 2026

Skyryse is a manufacturing firm that offers aerospace hardware and software operating systems and components design, production, and sales.

Aerospace · El Segundo$300.0M Series C
BarkBox
January 2026

Barkbox is a monthly subscription service platform that provides dog products.

E-Commerce · New York$35.0M Post Ipo Debt
Corvus Pharmaceuticals
January 2026

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.

Biopharma · Burlingame$201.0M Post Ipo Equity
PrognomiQ
January 2026

PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.

Biopharma · San Mateo$11.9M Series Unknown
Wasabi Technologies
January 2026

Wasabi Technologies provides secure cloud storage and data management solutions.

Cloud Data Services · Boston$70.0M Series E
Mirador Therapeutics
January 2026

Mirador Therapeutics develops precision medicines for immune-mediated diseases.

Biotechnology · San Diego$250.0M Series B
Century Therapeutics
January 2026

Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.

Biotechnology · Philadelphia$135.0M Post Ipo Equity
Monte Rosa Therapeutics
January 2026

Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.

Biotechnology · Basel$300.0M Post Ipo Equity
Lyte AI
January 2026

Lyte AI offers a low-code fintech platform that enables companies to build, launch, and scale digital banking and compliance tools.

Artificial Intelligence (AI) · Mountain View$107.0M Series Unknown
Vodafone Idea
December 2025

Vodafone Idea is an Indian telecom operator firm that provides pan India voice and data services to customers.

Information Technology · Mumbai$365.6M Post Ipo Debt
Kalaris Therapeutics (formerly AlloVir)
December 2025

AlloVir focuses on the development of cell therapies and focuses on restoring natural immunity against the virus-associated diseases.

Biotechnology · Houston$50.0M Post Ipo Equity
T1 Energy
December 2025

T1 Energy is a solar and battery manufacturing company for commercial and industrial sectors.

Battery · Austin$140.0M Post Ipo Equity
Tenaya Therapeutics
December 2025

Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.

Biopharma · San Francisco$60.0M Post Ipo Equity
Amaero International
December 2025

Amaero International is an Australian based company that manufactures large-format complex components in metal.

3D Printing · Notting Hill$22.8M Post Ipo Debt

Where Fidelity invests

Biotechnology9
Health Care6
Therapeutics5
Biopharma4
Medical4
Pharmaceutical4

About Fidelity's portfolio

How many companies has Fidelity invested in?▸

Fidelity has invested in 258 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Fidelity invest in?▸

Fidelity's top investment sectors include Biotechnology, Health Care, Therapeutics, Biopharma, Medical. The firm invests across 54 different industry categories.

What is Fidelity's largest investment?▸

Among tracked funding rounds, Vodafone Idea received $365.6M in a Post Ipo Debt round. Fidelity's total known invested capital is $29.2B.

What is the average investment size for Fidelity?▸

Fidelity's average investment size is $175.8M across its portfolio of 258 companies.

What are Fidelity's most recent investments?▸

Recent Fidelity portfolio additions include Metsera, Saluda Medical, Carbon, Ankyra, Starry. These companies were founded in 2020 or later.

Reach the founders behind these 258 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →